How is Azacitidine Different from Other Chemotherapeutic Agents?
Azacitidine is distinct from other chemotherapeutic agents due to its dual action as a hypomethylating agent and an RNA-incorporating agent. Its ability to target epigenetic modifications sets it apart from traditional chemotherapies that primarily target rapidly dividing cells. This unique mechanism of action allows azacitidine to be effective in cancers characterized by abnormal DNA methylation, providing a targeted therapeutic approach.